Vectus Biosystems Limited logo

Vectus Biosystems Limited

ASX:VBS.AX

Overview | Financials
Company Name Vectus Biosystems Limited
Symbol VBS.AX
Currency AUD
Price 0.08
Market Cap 4,256,840
Dividend Yield 0%
52-week-range 0.076 - 0.37
Industry Biotechnology
Sector Healthcare
CEO Dr. Karen Annette Duggan
Website https://www.vectusbiosystems.com.au

An error occurred while fetching data.

About Vectus Biosystems Limited

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis,

Related Stocks

PainChek Limited logo

PainChek Limited

PCK.AX

0.031 AUD

Imricor Medical Systems, Inc. logo

Imricor Medical Systems, Inc.

IMR.AX

0.525 AUD

Imagion Biosystems Limited logo

Imagion Biosystems Limited

IBX.AX

0.023 AUD

Dimerix Limited logo

Dimerix Limited

DXB.AX

0.38 AUD

Pharmaxis Ltd logo

Pharmaxis Ltd

PXS.AX

0.028 AUD

Patrys Limited logo

Patrys Limited

PAB.AX

0.006 AUD

Resonance Health Limited logo

Resonance Health Limited

RHT.AX

0.063 AUD

Neurotech International Limited logo

Neurotech International Limited

NTI.AX

0.063 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD